InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 143.44M.
Undervalued
The company’s latest PE is 26.47, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 16.62M shares, decreasing 11.38% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 1.28K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.81.